Snail as a potential target molecule in cardiac fibrosis: Paracrine action of endothelial cells on fibroblasts through snail and CTGF Axis

Molecular Therapy

Volumn 21, Issue 9, 2013, Pages 1767-1777

  Lee, Sae Won ^a   Won, Joo Yun ^a   Kim, Woo Jean ^b   Lee, Jaewon ^a   Kim, Kyung Hee ^a   Youn, Seock Won ^a   Kim, Ju Young ^a   Lee, Eun Ju ^a   Kim, Yong Jin ^a   Kim, Kyu Won ^c   Kim, Hyo Soo ^a,c  

^a Seoul National University Hospital   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; ROSIGLITAZONE; TRANSCRIPTION FACTOR SNAIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CELL SPECIFICITY; CELL TRANSDIFFERENTIATION; CELL TRANSFORMATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIAL TO MESENCHYMAL TRANSITION; ENDOTHELIUM CELL; FIBROBLAST; HEART FUNCTION; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; MALE; MOUSE; MYOBLAST; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN TARGETING; REOXYGENATION; REPERFUSION INJURY;

GASTROPODA;

ANIMALS; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIAL CELLS; FIBROSIS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOFIBROBLASTS; PPAR GAMMA; RATS; TRANSCRIPTION FACTORS;

EID: 84883739507     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.146     Document Type: Article

References (39)

1. Prasad, A, Stone, GW, Holmes, DR and Gersh, B (2009). Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion. Circulation 120: 2105-2112.
2. Lee, SW, Won, JY, Lee, HY, Lee, HJ, Youn, SW, Lee, JY et al. (2011). Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-?1/ERK/caspase-9 phosphorylation cascade. Mol Med 17: 1095-1106.
3. Khan, R and Sheppard, R (2006). Fibrosis in heart disease: understanding the role of transforming growth factor-in cardiomyopathy, valvular disease and arrhythmia. Immunology 118: 10-24.
4. Sun, Y (2009). Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res 81: 482-490.
5. Dai, B, Huang, W, Xu, M, Millard, RW, Gao, MH, Hammond, HK et al. (2011). Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function. J Am Coll Cardiol 58: 2118-2127.
6. McAnulty, RJ (2007). Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol 39: 666-671. (Pubitemid 46366802)
7. Piera-Velazquez, S, Li, Z and Jimenez, SA (2011). Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 179: 1074-1080.
8. Iwano, M, Plieth, D, Danoff, TM, Xue, C, Okada, H and Neilson, EG (2002). Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350. (Pubitemid 34847966)
9. Strutz, F (2008). How many different roads may a cell walk down in order to become a fibroblast? J Am Soc Nephrol 19: 2246-2248.
10. Zeisberg, EM, Tarnavski, O, Zeisberg, M, Dorfman, AL, McMullen, JR, Gustafsson, E et al. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961. (Pubitemid 47222040)
11. Barrallo-Gimeno, A and Nieto, MA (2005). The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132: 3151-3161. (Pubitemid 41167144)
12. Medici, D, Potenta, S and Kalluri, R (2011). Transforming growth factor-?2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smaddependent and Smad-independent signalling. Biochem J 437: 515-520.
13. Boutet, A, Esteban, MA, Maxwell, PH and Nieto, MA (2007). Reactivation of Snail genes in renal fibrosis and carcinomas: a process of reversed embryogenesis? Cell Cycle 6: 638-642. (Pubitemid 46535671)
14. Boutet, A, De Frutos, CA, Maxwell, PH, Mayol, MJ, Romero, J and Nieto, MA (2006). Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 25: 5603-5613. (Pubitemid 44847200)
15. Rowe, RG, Lin, Y, Shimizu-Hirota, R, Hanada, S, Neilson, EG, Greenson, JK et al. (2011). Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol Cell Biol 31: 2392-2403.
16. Nagarajan, D, Melo, T, Deng, Z, Almeida, C and Zhao, W (2012). ERK/GSK3?/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition. Free Radic Biol Med 52: 983-992.
17. Choudhary, R, Li, H, Winn, RA, Sorenson, AL, Weiser-Evans, MC and Nemenoff, RA (2010). Peroxisome proliferator-activated receptor-inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail. Neoplasia 12: 224-234.
18. Schulte, J, Weidig, M, Balzer, P, Richter, P, Franz, M, Junker, K et al. (2012). Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells. Histochem Cell Biol 138: 847-860.
19. Samah, M, El-Aidy, Ael-R, Tawfik, MK and Ewais, MM (2012). Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats. Eur J Pharmacol 689: 186-193.
20. Kiss, E, Popovic, ZV, Bedke, J, Adams, J, Bonrouhi, M, Babelova, A et al. (2010). Peroxisome proliferator-activated receptor (PPAR)can inhibit chronic renal allograft damage. Am J Pathol 176: 2150-2162.
21. Zeisberg, EM, Potenta, SE, Sugimoto, H, Zeisberg, M and Kalluri, R (2008). Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19: 2282-2287.
22. Tomasek, JJ, Gabbiani, G, Hinz, B, Chaponnier, C and Brown, RA (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-363. (Pubitemid 34619269)
23. Kalluri, R and Neilson, EG (2003). Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784. (Pubitemid 38063698)
24. Thiery, JP and Sleeman, JP (2006). Complex networks orchestrate epithelialmesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142. (Pubitemid 43278296)
25. Eisenberg, LM and Markwald, RR (1995). Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77: 1-6.
26. Zeisberg, EM, Potenta, S, Xie, L, Zeisberg, M and Kalluri, R (2007). Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67: 10123-10128. (Pubitemid 350070783)
27. Bradham, DM, Igarashi, A, Potter, RL and Grotendorst, GR (1991). Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114: 1285-1294. (Pubitemid 21909886)
28. Lau, LF and Lam, SC (1999). The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248: 44-57. (Pubitemid 29393928)
29. Chen, MM, Lam, A, Abraham, JA, Schreiner, GF and Joly, AH (2000). CTGF expression is induced by TGF-in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 32: 1805-1819.
30. Peinado, H, Quintanilla, M and Cano, A (2003). Transforming growth factor ?-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 278: 21113-21123. (Pubitemid 36806424)
31. Romagnoli, M, Belguise, K, Yu, Z, Wang, X, Landesman-Bollag, E, Seldin, DC et al. (2012). Epithelial-to-mesenchymal transition induced by TGF-?1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Res 72: 6268-6278.
32. Nissen, SE, Nicholls, SJ, Wolski, K, Nesto, R, Kupfer, S, Perez, A et al.; PERISCOPE Investigators. (2008). Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA 299: 1561-1573. (Pubitemid 351482795)
33. Mannucci, E, Monami, M, Lamanna, C, Gensini, GF and Marchionni, N (2008). Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials. Diabetes Obes Metab 10: 1221-1238.
34. Hahn, JY, Cho, HJ, Bae, JW, Yuk, HS, Kim, KI, Park, KW et al. (2006). Catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J Biol Chem 281: 30979-30989.
35. Mestril, R, Chi, SH, Sayen, MR, O'Reilly, K and Dillmann, WH (1994). Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against simulated ischemia-induced injury. J Clin Invest 93: 759-767. (Pubitemid 24072819)
36. Lee, SW, Jung, KH, Jeong, CH, Seo, JH, Yoon, DK, Suh, JK et al. (2011). Inhibition of endothelial cell migration through the down-regulation of MMP-9 by A-kinase anchoring protein 12. Mol Med Rep 4: 145-149.
37. Kim, WJ, Cho, H, Lee, SW, Kim, YJ and Kim, KW (2005). Antisense-thioredoxin inhibits angiogenesis via pVHL-mediated hypoxia-inducible factor-1degradation. Int J Oncol 26: 1049-1052.
38. Song, HS, Son, MJ, Lee, YM, Kim, WJ, Lee, SW, Kim, CW et al. (2002). Oxygen tension regulates the maturation of the blood-brain barrier. Biochem Biophys Res Commun 290: 325-331. (Pubitemid 34694503)
39. Lee, SW, Kim, WJ, Choi, YK, Song, HS, Son, MJ, Gelman, IH et al. (2003). SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 9: 900-906. (Pubitemid 36889933)